3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
8
Neoplasms
4
Multiple Myeloma
3
Radiation Injuries
2
Multiple Chronic Conditions
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Esophageal Neoplasms
2
Cognitive Dysfunction
2
Brain Neoplasms
2
Substance-Related Disorders
1
Sarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pathologic Complete Response
1
Pain
1
Osteosarcoma
1
Neoplasms, Second Primary
1
Neoplasms, Plasma Cell
1
Nasopharyngeal Neoplasms
1
Nasopharyngeal Carcinoma
1
Mobility Limitation
1
Melanoma
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Leukemia
1
Kidney Neoplasms
1
Hyperthermia
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Interventions
Diathermy
20
Radiotherapy
11
Fluorouracil
4
Drug Therapy
4
Cisplatin
4
Radiation
3
Immune Checkpoint Inhibitors
3
Brachytherapy
3
tislelizumab
2
Surgical Procedures, Operative
2
Solutions
2
Immunotherapy
2
Hyperthermia, Induced
2
Hydrogen Peroxide
2
Conization
2
Capecitabine
2
spartalizumab
1
anlotinib
1
Temozolomide
1
Saline Solution
1
Radiation Dose Hypofractionation
1
Patient Reported Outcome Measures
1
Paclitaxel
1
Oxaliplatin
1
Mitomycin
1
Ifosfamide
1
Hyperthermic Intraperitoneal Chemotherapy
1
Gemcitabine
1
Folfox protocol
1
Doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Hyperthermia
×
Patient Reported Outcome Measures
×
Clear all
NCT06452485
2025-10-06
RT-HYPE
Amsterdam UMC, location VUmc
Recruiting
500 enrolled